Transfusion With 2 L of Hyperimmune Plasma is Superior to Transfusion of 1 L or Less for Protecting Foals Against Subclinical Pneumonia Attributed to Rhodococcus equi.
Authors: Kahn Susanne K, Blodgett Glenn P, Canaday Nathan M, Bevevino Kari E, Rocha Joana N, Bordin Angela I, Cohen Noah D
Journal: Journal of equine veterinary science
Summary
# Editorial Summary: Rhodococcus equi Hyperimmune Plasma Dosing in Foals Rhodococcus equi pneumonia represents a significant disease burden on breeding farms, yet much remains unclear about the protective efficacy of hyperimmune plasma transfusions—a cornerstone of preventative protocols at many large studs. Kahn and colleagues conducted a retrospective analysis of 149 foals at a single breeding operation, comparing subclinical pneumonia detection rates (via thoracic ultrasonography at 5, 7, and 9 weeks of age) between foals receiving either ≤1 L or 2 L of Rhodococcus equi hyperimmune plasma within 36 hours of birth. Foals transfused with 2 L demonstrated substantially lower disease incidence at 12%, versus 32% in those receiving less than 1 L—a statistically significant difference (P = 0.0068). For practitioners, these findings suggest that volume matters considerably: doubling the plasma dose from standard 1 L protocols markedly reduces the likelihood of subclinical infection detection, with clear implications for disease prevention strategy and, importantly, reduced need for antimicrobial therapy and associated resistance concerns. Whilst acknowledging the observational nature of the data, the authors appropriately call for prospective, controlled trials to establish optimal dosing protocols and confirm causality—a pathway that could substantially refine current preventative practices across the equine industry.
Read the full abstract on PubMed
Practical Takeaways
- •Consider transfusing foals at risk for R. equi with 2 L of hyperimmune plasma rather than 1 L or less, as this volume showed superior protection against subclinical pneumonia in this farm population
- •Implement routine thoracic ultrasonography screening of foals at 5, 7, and 9 weeks of age to detect subclinical pneumonia early and avoid unnecessary antibiotic treatment that drives resistance
- •Recognize this is observational data with significant limitations; await results from properly designed clinical trials before changing established protocols at your facility
Key Findings
- •Foals receiving <1 L of hyperimmune plasma had significantly higher incidence of subclinical pneumonia (32%) compared to those receiving 2 L (12%; P=0.0068)
- •Transfusion volume was primarily determined by intended use of foals rather than randomized allocation, limiting causal inference
- •Thoracic ultrasonography screening at 5, 7, and 9 weeks of age detected most subclinical R. equi pneumonia cases on the farm
- •Results suggest 2 L REHIP transfusion is more protective than 1 L or less, but well-designed RCTs are needed to confirm dose-response